麦克森Mckesson（MCK）2026财年第二季度业绩报告「NYSE」（英文版）（17页）.pdf

1、 1 See below under Fiscal 2026 Outlook for full explanation 2 Adjusted results in this earnings release are non-GAAP financial measures;refer to the accompanying definitions and reconciliation schedules McKESSON CORPORATION REPORTS FISCAL 2026 SECOND QUARTER RESULTS AND RAISES FULL YEAR ADJUSTED EPS

2、 GUIDANCE IRVING,Texas,November 5,2025-McKesson Corporation(NYSE:MCK)today announced results for the second quarter ended September 30,2025.Second Quarter Highlights:Quarterly consolidated revenues increased to a record high of$103.2 billion,an increase of 10%compared to the prior year.Earnings per

3、diluted share of$8.92 increased$7.05.Adjusted Earnings per Diluted Share of$9.86 increased 39%.Generated$2.4 billion of cash flow from operations and$2.2 billion of Free Cash Flow.Fiscal 2026 Full Year Outlook:Raised Adjusted Earnings per Diluted Share guidance range to$38.35 to$38.85,from the previ

4、ous range of$38.05 to$38.55.Fiscal 2026 Adjusted Earnings per Diluted Share guidance range indicates 16%to 18%growth compared to the prior year.The Company does not forecast GAAP earnings per diluted share1.“McKessons second quarter results underscore the strength of our differentiated assets,capabi

5、lities,and continued momentum as a diversified healthcare services leader.We delivered record revenue in the quarter of$103 billion,increasing 10%and Adjusted Earnings per Diluted Share accelerating 39%compared to the prior year.These results reflect disciplined execution of our enterprise strategy

6、advancing growth in oncology and multispecialty and biopharma services.We remain confident in our ability to create value for our customers,partners,employees,and shareholders,”said Brian Tyler,chief executive officer.“These achievements reflect the dedication of McKesson employees and their unwaver